<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>9fe06ad4-4741-4f36-bb0c-36deafe261b7</id>
  <name>Palliative Acute Care Admission Medication Order Panel</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~9fe06ad4-4741-4f36-bb0c-36deafe261b7~NAME~Palliative Acute Care Admission Medication Order Panel}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antifungals&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;nystatin cream 100 000 unit/g&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;apply to affected *** area *** times per day&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Opioid analgesics are commonly used to treat pain related to progressive and advanced disease. Due to wide variations in pharmacokinetics, bioavailability, metabolism and response in patients, opioid doses cannot be estimated or calculated in advance (NICE, 2016), and therefore are not included in this order set. Opioid selection and dose titration must be individualized to account for the patient’s disease burden, prognosis, pain severity, previous use of opioids, history of substance use disorder, presence of hepatic or renal impairment, and other individual variables. If clinically appropriate, opioid analgesics can be ordered as individual items, separate from the order set.&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ibuprofen tablet; 200 mg PO every 8 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Maximum 1200 mg per day&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ibuprofen tablet; 200 mg PO every 4 hours PRN for pain.&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Maximum 1200 mg per day&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;PO administration or slow infusion via IV are preferred for metoclopramide to reduce the risk of extrapyramidal syndromes such as akathisia.&amp;nbsp; Suggest 5mg for mild to moderate nausea or if CrCl less than 40 mL/min; 10 mg for moderate to severe nausea, and CrCl over 40 mL/min&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ondansetron tablet orally disintegrating; 4 mg PO every 8 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Restricted to use with patients who have difficulty swallowing tablets or capsules OR patients actively vomiting without established IV access&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ondansetron tablet orally disintegrating; 4 mg PO every 8 hours PRN for nausea and/or vomiting&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Restricted to use with patients who have difficulty swallowing tablets or capsules OR patients actively vomiting without established IV access&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laxatives&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;Hyperlink &quot;AHS Pharmacy Services table&quot; with the hyperlink:&amp;nbsp;https://insite.albertahealthservices.ca/Main/assets/tms/phm/tms-phm-pub-dtb-oic-supplement.pdf&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;For dosing of laxatives for treatment of opioid-induced constipation refer to AHS Pharmacy Services table. &lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Sedatives and Hypnotics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Sleep Promotion:&amp;nbsp; Implement non-pharmacological sleep promotion measures (warm milk; warm blankets; hand rub; low light/minimize noise; calm approach; avoid caffeinated beverages).&amp;nbsp; If pharmacologic assistance is required low dose is advised.&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Other&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;midazolam injection; 5 mg IV/SUBCUTANEOUSLY every 1 hour PRN for refractory active seizure greater than 2 min and/or massive distressing hemorrhage.&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Notify MRHP if midazolam is ineffective&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Palliative Acute Care Admission Medication Order Panel">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Antifungals">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b042c515-ee2c-4ede-a97c-d0f32ac2f018" concept_name="PHARM NYSTATIN 100000 UNIT ML ORAL SUSPENSION [5751] Order" max="1" path="/items" name="nystatin liquid oral 100 000 unit/mL; 500,000 units SWISH and SWALLOW QID for 7 days then reassess"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="02fac822-e4c5-401a-90d1-462f8bcc751c" concept_name="PHARM NYSTATIN 100000 UNIT GRAM TOPICAL CREAM [5749] Order" max="1" path="/items" name="nystatin cream 100 000 unit/g"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Analgesic and Antipyretics">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen tablet Compiled Order" max="1" path="/items" name="acetaminophen tablet; 325 mg PO every 6 hour"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen tablet Compiled Order" max="1" path="/items" name="acetaminophen tablet; 325 mg PO every 6 hours PRN for pain and mild fever"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen tablet Compiled Order" max="1" path="/items" name="ibuprofen tablet; 200 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen tablet Compiled Order" max="1" path="/items" name="ibuprofen tablet; 200 mg PO every 4 hours PRN for pain."/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Antiemetics">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide tablet Compiled Order" max="1" path="/items" name="metoclopramide tablet; 10 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide tablet Compiled Order" max="1" path="/items" name="metoclopramide tablet; 10 mg PO every 8 hours PRN for nausea and/or vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM METOCLOPRAMIDE INJECTION ORDERABLE [4200105] Order" max="1" path="/items" name="metoclopramide IV/IM/SC; 10 mg IV/SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM METOCLOPRAMIDE INJECTION ORDERABLE [4200105] Order" max="1" path="/items" name="metoclopramide IV/IM/SC; 10 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron tablet Compiled Order" max="1" path="/items" name="ondansetron tablet; 4 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron tablet Compiled Order" max="1" path="/items" name="ondansetron tablet; 4 mg PO every 8 hours PRN for nausea and/or vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron tablet orally disintegrating Compiled Order" max="1" path="/items" name="ondansetron tablet orally disintegrating; 4 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron tablet orally disintegrating Compiled Order" max="1" path="/items" name="ondansetron tablet orally disintegrating; 4 mg PO every 8 hours PRN for nausea and/or vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ONDANSETRON INJECTION ORDERABLE [4200333] Order" max="1" path="/items" name="ondansetron injection; 4 mg IV/SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ONDANSETRON INJECTION ORDERABLE [4200333] Order" max="1" path="/items" name="ondansetron injection; 4 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Gastrointestinal Agents">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ce6336c2-0c67-492a-98f2-5f64630d4245" concept_name="PHARM OCTREOTIDE INJECTION ORDERABLE [420075] Order" max="1" path="/items" name="octreotide injection; 100 mcg SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f5df0026-4c75-406d-bb2e-4773e1c528b2" concept_name="PHARM PANTOPRAZOLE MAGNESIUM 40 MG TABLETDELAYED RELEASE [163115] Order" max="1" path="/items" name="pantoprazole magnesium tablet enteric-coated; 40 mg PO every 12 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c8e60c0b-e28c-475c-83c5-2d3e7186edb0" concept_name="PHARM raNITIdine tablet Compiled Order" max="1" path="/items" name="raNITIdine tablet; 150 mg PO every 12 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4289ae0a-6696-42a0-a472-5dac79de66b0" concept_name="PHARM HYOSCINE BUTYLBROMIDE IV IM SC ORDERABLE [4200503] Order" max="1" path="/items" name="hyoscine butylbromide IV/IM/SC; 10 mg SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a50383f2-2468-43f0-9868-2a26bbd0a054" concept_name="PHARM FAMOTIDINE INJECTION ORDERABLE [420210] Order" max="1" path="/items" name="famotidine injection; 20 mg, subcutaneous, every 12 hours"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laxatives">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1071327b-42fc-4918-80d7-5580f593434a" concept_name="PHARM BISACODYL 5 MG TABLETDELAYED RELEASE [1079] Order" max="1" path="/items" name="bisaCODyl tablet enteric-coated; 10 mg PO every 24 hours PRN for constipation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b7a7e48f-eb4a-47e2-82f9-c191ebd189f1" concept_name="PHARM BISACODYL 10 MG RECTAL SUPPOSITORY [1080] Order" max="1" path="/items" name="bisaCODyl (DULCOLAX) suppository; PR every 24 hours PRN for constipation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c67adad-7403-4f0b-881e-1a44ddac56a1" concept_name="PHARM LACTULOSE 10 GRAM 15 ML ORAL SOLUTION [38245] Order" max="1" path="/items" name="lactulose Oral liquid 667 mg/mL; 15 mL PO every 12 hours for constipation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c67adad-7403-4f0b-881e-1a44ddac56a1" concept_name="PHARM LACTULOSE 10 GRAM 15 ML ORAL SOLUTION [38245] Order" max="1" path="/items" name="lactulose Oral liquid 667 mg/mL; 15 mL PO every 24 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1d48b2f1-3f85-465b-8e2f-00039a0b31b6" concept_name="PHARM POLYETHYLENE GLYCOL 3350 POWDER ORDERABLE [4201136] Order" max="1" path="/items" name="polyethylene glycol 3350 powder; 17 grams PO every 24 hours PRN for constipation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e3097b98-bb4b-4ff0-8d67-c0d87fa81362" concept_name="PHARM SENNOSIDES 8.6 MG TABLET [11349] Order" max="1" path="/items" name="sennosides tablet; 17.2 mg PO every 12 hours PRN for constipation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e3097b98-bb4b-4ff0-8d67-c0d87fa81362" concept_name="PHARM SENNOSIDES 8.6 MG TABLET [11349] Order" max="1" path="/items" name="sennosides tablet; 17.2 mg PO every bedtime"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Central Nervous System Agents">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35f4467d-377f-4566-9ac3-01a0af1537d1" concept_name="PHARM haloperidol tablet Compiled Order" max="1" path="/items" name="haloperidol tablet; 1 mg PO every 8 hours PRN for nausea and/or vomiting and/or agitation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35f4467d-377f-4566-9ac3-01a0af1537d1" concept_name="PHARM haloperidol tablet Compiled Order" max="1" path="/items" name="haloperidol tablet; 1 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d22d5b2-02b0-42ed-9870-188ce381b761" concept_name="PHARM HALOPERIDOL INJECTION ORDERABLE [4200502] Order" max="1" path="/items" name="haloperidol injection; 1 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting and/or agitation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d22d5b2-02b0-42ed-9870-188ce381b761" concept_name="PHARM HALOPERIDOL INJECTION ORDERABLE [4200502] Order" max="1" path="/items" name="haloperidol injection; 1 mg IV/SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5fef6796-9e19-4737-8891-4980937e6343" concept_name="PHARM methotrimeprazine tablet Compiled Order" max="1" path="/items" name="methotrimeprazine tablet; 12.5 mg PO every 8 hours PRN for nausea and/or vomiting and/or agitation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5fef6796-9e19-4737-8891-4980937e6343" concept_name="PHARM methotrimeprazine tablet Compiled Order" max="1" path="/items" name="methotrimeprazine tablet; 12.5 mg PO every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1941460d-469a-4cd1-b597-9e7ba8cb3711" concept_name="PHARM METHOTREMPRAZINE INJECTION ORDERABLE [4200565] Order" max="1" path="/items" name="methotrimeprazine injection; 12.5 mg IV/SUBCUTANEOUSLY every 8 hours PRN for agitation"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1941460d-469a-4cd1-b597-9e7ba8cb3711" concept_name="PHARM METHOTREMPRAZINE INJECTION ORDERABLE [4200565] Order" max="1" path="/items" name="methotrimeprazine injection; 12. 5 mg IV/SUBCUTANEOUSLY every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="18aa04db-e8be-486b-8e36-efaee72ff067" concept_name="PHARM OLANZapine tablet Compiled Order" max="1" path="/items" name="OLANZapine tablet; 2.5 mg PO every 12 hours PRN for anxiety and/or agitation and/or nausea/vomiting"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="18aa04db-e8be-486b-8e36-efaee72ff067" concept_name="PHARM OLANZapine tablet Compiled Order" max="1" path="/items" name="OLANZapine tablet; 5 mg PO at bedtime"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c640cdd5-18b1-419e-a352-4c37c29fc4b0" concept_name="PHARM OLANZapine tablet orally disintegrating Compiled Order" max="1" path="/items" name="OLANZapine tablet orally disintegrating; 5 mg PO every 24 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c640cdd5-18b1-419e-a352-4c37c29fc4b0" concept_name="PHARM OLANZapine tablet orally disintegrating Compiled Order" max="1" path="/items" name="OLANZapine tablet orally disintegrating; 2.5 mg PO every 12 hours PRN for anxiety and/or agitation and/or nausea/vomiting"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Sedatives and Hypnotics">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="9605575f-0743-46c5-b7f1-70302015c570" concept_name="PHARM zopiclone tablet Compiled Order" max="1" path="/items" name="zopiclone tablet; 3.75 mg PO every HS"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fdf81754-7b74-4233-9e72-ea993b94e65f" concept_name="PHARM mirtazapine tablet Compiled Order" max="1" path="/items" name="mirtazapine tablet; 7.5 mg PO every HS"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Other">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="aa4c20bb-5d80-4726-9ce7-2a979e32d4f2" concept_name="PHARM dexAMETHasone tablet Compiled Order" max="1" path="/items" name="dexAMETHasone tablet; 6 mg PO every 24 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d0c9c00c-2757-42de-be79-7e4716a04e95" concept_name="PHARM DEXAMETHASONE INJECTION ORDERABLE [420206] Order" max="1" path="/items" name="dexAMETHasone Injection; 6 mg IV/SUBCUTANEOUSLY every 24 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e8443d3-a1d0-42b3-b9b2-b80bf7d202de" concept_name="PHARM MIDAZOLAM INJECTION ORDERABLE [4200215] Order" max="1" path="/items" name="midazolam injection; 5 mg IV/SUBCUTANEOUSLY every 1 hour PRN for refractory active seizure greater than 2 min and/or massive distressing hemorrhage."/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e8443d3-a1d0-42b3-b9b2-b80bf7d202de" concept_name="PHARM MIDAZOLAM INJECTION ORDERABLE [4200215] Order" max="1" path="/items" name="midazolam injection; 2 mg IV/SUBCUTANEOUSLY every 1 hour PRN for ***"/>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
</template>